BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23893151)

  • 1. Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population.
    Umamaheswaran G; Dkhar SA; Kalaivani S; Anjana R; Revathy M; Jaharamma M; Shree KM; Kadambari D; Adithan C
    Med Oncol; 2013; 30(3):665. PubMed ID: 23893151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic genetic variations of cytochrome P450 19A1 and T-cell leukemia 1A genes in the Tamil population.
    Umamaheswaran G; Kadambari D; Kumar AS; Revathy M; Anjana R; Adithan C; Dkhar SA
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):102-13. PubMed ID: 25481307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of aromatase gene (CYP19A1) in essential hypertension.
    Shimodaira M; Nakayama T; Sato N; Saito K; Morita A; Sato I; Takahashi T; Soma M; Izumi Y
    Int J Med Sci; 2008 Feb; 5(1):29-35. PubMed ID: 18274619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population.
    Lee SJ; Kim WY; Choi JY; Lee SS; Shin JG
    J Hum Genet; 2010 Mar; 55(3):189-93. PubMed ID: 20186154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic and allelic variability in CYP19A1 among populations of African and European ancestry.
    Starlard-Davenport A; Orloff MS; Dhakal I; Penney RB; Kadlubar SA
    PLoS One; 2015; 10(2):e0117347. PubMed ID: 25647083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CYP19A1 single-nucleotide polymorphism with digit ratio (2D:4D) in a sample of men and women from Ningxia (China).
    Zhanbing M; Jie D; Chunyue B; Hong L; Liang P; Zhenghao H
    Early Hum Dev; 2019 May; 132():58-65. PubMed ID: 30986648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity.
    Umamaheswaran G; Kadambari D; Muthuvel SK; Kalaivani S; Devi J; Damodaran SE; Pradhan SC; Dubashi B; Dkhar SA; Adithan C
    Breast Cancer Res Treat; 2020 Jul; 182(1):147-158. PubMed ID: 32385792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.
    Artigalás O; Vanni T; Hutz MH; Ashton-Prolla P; Schwartz IV
    BMC Med; 2015 Jun; 13():139. PubMed ID: 26067721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
    Haiman CA; Dossus L; Setiawan VW; Stram DO; Dunning AM; Thomas G; Thun MJ; Albanes D; Altshuler D; Ardanaz E; Boeing H; Buring J; Burtt N; Calle EE; Chanock S; Clavel-Chapelon F; Colditz GA; Cox DG; Feigelson HS; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn JN; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Lenner P; Lund E; Panico S; Peeters PH; Pike MC; Riboli E; Tjonneland A; Travis R; Trichopoulos D; Wacholder S; Ziegler RG
    Cancer Res; 2007 Mar; 67(5):1893-7. PubMed ID: 17325027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between rs10046, rs1143704, rs767199, rs727479, rs1065778, rs1062033, rs1008805, and rs700519 polymorphisms in aromatase (CYP19A1) gene and Alzheimer's disease risk: a systematic review and meta-analysis involving 11,051 subjects.
    Song Y; Lu Y; Liang Z; Yang Y; Liu X
    Neurol Sci; 2019 Dec; 40(12):2515-2527. PubMed ID: 31278540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
    Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
    Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.
    Kanda S; Tsuchiya N; Narita S; Inoue T; Huang M; Chiba S; Akihama S; Saito M; Numakura K; Tsuruta H; Satoh S; Saito S; Ohyama C; Arai Y; Ogawa O; Habuchi T
    Int J Cancer; 2015 Jan; 136(1):74-82. PubMed ID: 24803183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.
    Ferraldeschi R; Arnedos M; Hadfield KD; A'Hern R; Drury S; Wardley A; Howell A; Evans DG; Roberts SA; Smith I; Newman WG; Dowsett M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1191-8. PubMed ID: 22418701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy.
    Shimodaira M; Nakayama T; Sato I; Sato N; Izawa N; Mizutani Y; Furuya K; Yamamoto T
    Endocrine; 2012 Dec; 42(3):700-7. PubMed ID: 22638611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.
    Alwan AM; Afzaljavan F; Tavakol Afshari J; Homaei Shandiz F; Barati Bagherabad M; Vahednia E; Kheradmand N; Pasdar A
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1705. PubMed ID: 34014013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between CYP19A1 genotype and pubertal sagittal jaw growth.
    He S; Hartsfield JK; Guo Y; Cao Y; Wang S; Chen S
    Am J Orthod Dentofacial Orthop; 2012 Nov; 142(5):662-70. PubMed ID: 23116507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.
    Lunardi G; Piccioli P; Bruzzi P; Notaro R; Lastraioli S; Serra M; Marroni P; Bighin C; Mansutti M; Puglisi F; Porpiglia M; Ponzone R; Bisagni G; Garrone O; Cavazzini G; Clavarezza M; Del Mastro L
    Breast Cancer Res Treat; 2013 Jan; 137(1):167-74. PubMed ID: 23129173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP19A1 rs2470152 polymorphism increases susceptibility to depression in Chinese Han population.
    Yang Y; Yan H; Kong Y; Liu L; Peng Q; Wen Y; Zhou Z; Chang Q
    Neurosci Lett; 2019 Nov; 713():134490. PubMed ID: 31518674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Lv F; Huang W; Wang Y
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):486-495. PubMed ID: 34280004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.